ISSCR News
Member Spotlight: Haruhisa Inoue, MD, PhD
It is invaluable to be able to connect with colleagues from around the world who share common goals and objectives, and to have face-to-face, direct discussions with researchers of different generations.
ISSCR Journal Stem Cell Reports Named Official Conference Journal for BaCell 3D Conference
Stem Cell Reports, the premier open-access journal dedicated to advancing stem cell research, has been named the official conference journal for BaCell 3D, taking place from 23-25 June 2025, in Basel, Switzerland.
Stem Cell Transplant Clears Clinical Safety Hurdle for the Treatment of Wet Age-Related Macular Degeneration
Wet AMD in its early stages can be treated with drugs to reduce the formation of new blood vessels, but this treatment is inefficient in cases where blood vessel formation is already in its advanced stages. A new, alternative treatment for those patients may be surgical removal of the abnormal blood vessels followed by the transplantation of stem cell-derived retinal cells, according to a recent study led by Yong Liu and colleagues from Third Military Medical University Southwest Hospital, China, published in the journal Stem Cell Reports.
The ISSCR Signs on to Coalition Letter in Support of NIH
The ISSCR joined with Research!America, hundreds of biomedical research organizations, and thousands of private citizens from the U.S. scientific community to urge House and Senate appropriators to avoid a full-year continuing resolution for Fiscal Year 2025 appropriations and instead provide a robust funding increase for the National Institutes of Health (NIH). The letter also calls for the preservation of existing protections against cuts to reimbursement for NIH grantee Facilities and Administrative costs. These drastic cuts will slow scientific progress and weaken the U.S. research ecosystem.
The ISSCR Encourages Japanese Policymakers to Increase Oversight of Regenerative Medicine Interventions
Today, the ISSCR sent a letter to Japan’s Ministry of Health, Labour, and Welfare encouraging the Ministry to implement regulations that adhere as closely as possible to international guidelines for the administration of regenerative medicine interventions.
In the letter, shared in response to amendments to the Act on the Safety of Regenerative Medicine (ASRM), the ISSCR commends Japan for taking steps to strengthen the ASRM to protect patient safety and offers recommendations citing this opportunity to strengthen Japan’s approach to regenerative medicine oversight.
Receive ISSCR Press Releases
Sign up be a part of ISSCR’s media list. Media Contact: Kym Kilbourne, Director of Media and Strategic Communications
Subscribe to ISSCR News.
Each month, ISSCR delivers scientific, policy, and community to your inbox .